Chembio Diagnostic Systems, Inc. (NASDAQ: CEMI) develops, manufactures, licenses and markets point-of-care (POC) diagnostic tests and technology for the detection of infectious diseases. Founded in 1985 to develop products used in diagnostic laboratories, Chembio entered the POC testing field in the late 1990s and, in 2002, focused its business to participate in the emerging global need and opportunity for rapid HIV tests. The Company became public in 2004 and is now a leading employer on Long Island, New York, with approximately 200 employees. Revenues during 2013 approached $30MM.  More »



Recent Releases

Apr 4, 2017
Chembio and FIND Collaborate to Develop Point-of-Care Multiplex Test for Acute Febrile Illnesses in Asia Pacific

Mar 7, 2017
Chembio Diagnostics Reports 2016 Financial Results

View all releases »

Financial Reports

2014 Annual Report
Filed on Mar 4, 2015


2016 Annual Report
Filed on Mar 7, 2017


Q3 2016 Quarterly Report
Filed on Nov 10, 2016


Q2 2016 Quarterly Report
Filed on Aug 11, 2016


10-Q/A
Filed on Jun 3, 2016


Q1 2016 Quarterly Report
Filed on May 12, 2016


View all filings »

Featured Presentations

March 2017 Investor Presentation

March 2017 Fact Sheet

Print Print Page  |  Email Email Page